Repeated neurofilament light chain measurements did not capture Riluzole therapeutic effect in amyotrophic lateral sclerosis patients

BACKGROUND: Little is known about the influence of Riluzole on serum neurofilament light chain (sNfL) levels, a biomarker of prognosis in amyotrophic lateral sclerosis (ALS), and variations with time of sNfL concentrations are controversial. METHODS: Sera from ALS patients (n = 141) and controls (n ...

Descripción completa

Detalles Bibliográficos
Autores principales: Esselin, Florence, De la Cruz, Elisa, Hirtz, Christophe, Tiers, Laurent, Alphandery, Sébastien, Baudesson, Léandra, Taieb, Guillaume, Camu, William, Lehmann, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437233/
https://www.ncbi.nlm.nih.gov/pubmed/35751632
http://dx.doi.org/10.1111/cns.13894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437233/
https://www.ncbi.nlm.nih.gov/pubmed/35751632
http://dx.doi.org/10.1111/cns.13894

Ejemplares similares